| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Motilal Oswal Nifty MidSmall Healthcare Index Fund Reg (G) |
| [Equity: Index] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
0.25 |
| Equity |
99.75 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
38.86% |
| Top 10 Holdings |
61.33% |
| Top 25 Holdings |
93.71% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
75.71 |
| Healthcare |
24.04 |
| Cash |
0.25 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
4.88 |
| PE Ratio |
39.32 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Lupin Limited |
10.09 |
| Fortis Health Care Ltd |
8.57 |
| Laurus Labs Limited |
7.25 |
| Aurobindo Pharma Limited |
6.53 |
| Alkem Laboratories Limited |
6.42 |
| Glenmark Pharmaceuticals Limited |
5.87 |
| Biocon Limited |
5.06 |
| Mankind Pharma Limited |
4.64 |
| IPCA Laboratories Limited |
3.95 |
| J B Chemicals and Pharma Ltd |
2.95 |
| Krishna Inst of Medical Sciences Ltd. |
2.88 |
| Gland Pharma Limited |
2.84 |
| Abbott India Limited |
2.79 |
| Aster DM Healthcare Limited |
2.48 |
| Narayana Hrudalaya Ltd |
2.32 |
| Ajanta Pharma Limited |
2.27 |
| Wockhardt Limited |
2.21 |
| Neuland Laboratories Limited |
2.20 |
| Dr Lal Path Labs Ltd |
2.11 |
| Glaxosmithkline Pharma Ltd |
1.92 |
| Piramal Pharma Limited |
1.85 |
| Syngene International Limited |
1.74 |
| EQ- GLOBAL HEALTH LTD. |
1.72 |
| Granules India Limited |
1.60 |
| Natco Pharma Limited |
1.45 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
